2[1]Bjorklund A, Lindvall O. Cell replacement therapies for central nervous system disorders. Nat Neurosci, 2000, 3(6): 537～544 被引量：1
3[2]Zao D L, Potter E D, Carvy P M, et al. Differentiation of mesencephalic progeniror cells into dopaminergic neurons by cytokines. Exp Neuro, 1998, 149: 411～423 被引量：1
4[3]Rice M E. Ascorbic regulation and its neuroprotective role in the brain. Trends Neurosci, 2000, 23: 209～216 被引量：1
5[4]Rebec G V, Pierce R C. A vitamin as neuromodulator--ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission. Prog Neurobiol, 1994, 43: 537～565 被引量：1
6[5]Akamatsu W, Okano H. Neural stem cell, as a source of graft material for transplantation in neuronal disease. No To Hattatsu, 2001, 33(2): 114～120 被引量：1
7[7]Rossi F, Cattaneo E. Neural stem cell therapy for neurological diseases: dreams and reality. Nature, 2002, 3: 401～409 被引量：1
8[8]Dobrossy M D, Dunnett S B. The influence of the environment and experience on neural grafts. Nature Rev Neurosci, 2001, 2: 871～879 被引量：1
9[9]Carvey P M, Ling Z D, Sortwell C E, et al. A clonal line of mesencephalic progeniror cells converted to dopamine neurons by hematopoietic cytokines:a source of cells for transplantation in Parkinson's disease. Exp Neuro, 2002, 171: 98～108 被引量：1
10[10]Yan J, Studer L, Mckay R D, et al. Ascorbic acid increases the yield of dopaminergic neurons derived from basic fibroblast growth factor expanded mesencephalic precursors. J Neurochem, 2001, 36: 307～311 被引量：1
